Klotho Neurosciences Statistics
Total Valuation
KLTO has a market cap or net worth of $39.57 million. The enterprise value is $31.14 million.
Important Dates
The next estimated earnings date is Tuesday, November 18, 2025, after market close.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KLTO has 70.33 million shares outstanding. The number of shares has increased by 73.88% in one year.
| Current Share Class | 70.33M |
| Shares Outstanding | 70.33M |
| Shares Change (YoY) | +73.88% |
| Shares Change (QoQ) | +23.36% |
| Owned by Insiders (%) | 15.33% |
| Owned by Institutions (%) | 3.61% |
| Float | 56.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.78 |
| P/TBV Ratio | 4.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 135.74
| Current Ratio | 135.74 |
| Quick Ratio | 133.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.09 |
Financial Efficiency
Return on equity (ROE) is -249.56% and return on invested capital (ROIC) is -78.87%.
| Return on Equity (ROE) | -249.56% |
| Return on Assets (ROA) | -72.43% |
| Return on Invested Capital (ROIC) | -78.87% |
| Return on Capital Employed (ROCE) | -76.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.78M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.30% in the last 52 weeks. The beta is 2.40, so KLTO's price volatility has been higher than the market average.
| Beta (5Y) | 2.40 |
| 52-Week Price Change | -1.30% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 47.55 |
| Average Volume (20 Days) | 2,584,905 |
Short Selling Information
The latest short interest is 1.08 million, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 1.08M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 1.54% |
| Short % of Float | 1.90% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.20M |
| Pretax Income | -11.35M |
| Net Income | -11.35M |
| EBITDA | n/a |
| EBIT | -8.20M |
| Earnings Per Share (EPS) | -$0.42 |
Full Income StatementBalance Sheet
The company has $8.43 million in cash and n/a in debt, giving a net cash position of $8.43 million or $0.12 per share.
| Cash & Cash Equivalents | 8.43M |
| Total Debt | n/a |
| Net Cash | 8.43M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 10.65M |
| Book Value Per Share | 0.20 |
| Working Capital | 8.48M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.54M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
